Comparing the Safety Profiles of two NaPi2b ADCs Produced using Different Platforms

Time: 9:00 am
day: Conference Day 1

Details:

  • Optimizing an ADC platform to minimize platform off-target toxicity
  • Comparing two NaPi2b ADCs produced using two different platforms, improving safety and efficacy both pre-clinically and clinically
  • Leveraging the rat versus NHPs, for investigative mechanistic studies

Speakers: